Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.50−0.33 (-8.62%)
Close on Nov 17, 2026Market cap $71.86KP/E –Yield –
Addex Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Addex Therapeutics's enterprise value was -$873.54K on Nov 11, 2026, against -$2.71M a year earlier. Over the last 5 years it ranged from -$21.76M to -$858.87K, with a median of -$4.23M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$873.54K | – |
| 2025 | Dec 31, 2025 | -$2.75M | – |
| 2024 | Dec 31, 2024 | -$4.14M | – |
| 2023 | Dec 29, 2023 | -$8.45M | – |
| 2022 | Dec 30, 2022 | -$9.47M | – |
| 2021 | Dec 31, 2021 | -$19.97M | – |
| 2020 | Dec 31, 2020 | -$34.68M | – |
See a number that looks wrong?